Hepatitis C Cases by Country
Discover detailed Hepatitis C statistics across 187 countries, including both active cases and treatment success data. Track global progress toward HCV elimination with our comprehensive database showing the impact of modern antiviral therapies worldwide.
Global Hepatitis C Statistics 2022
Hepatitis C (HCV) is a viral infection that causes liver inflammation, potentially leading to serious liver damage. Our comprehensive database presents detailed statistics from 187 countries, showing both active chronic Hepatitis C cases and total numbers including successfully treated patients, providing crucial insights into global treatment progress.
Unlike Hepatitis B, Hepatitis C can be cured with antiviral medications. Modern direct-acting antivirals (DAAs) have revolutionized HCV treatment, achieving cure rates exceeding 95% with treatment courses lasting 8-12 weeks. This breakthrough has transformed Hepatitis C from a chronic, life-threatening condition into a curable disease. Our data presents two key metrics: active chronic cases and total cases including those who have been successfully treated. The difference between these numbers reveals the remarkable impact of treatment programs worldwide, particularly in countries with robust healthcare systems and treatment access. The 2022 data reveals significant variations in both disease burden and treatment success. Pakistan reports the highest number of active cases with approximately 8.8 million people, followed by Russia (2.7 million) and Egypt (484,000). However, Egypt's total including treated cases reaches 4.3 million, demonstrating one of the world's most successful national Hepatitis C elimination programs. Eastern Mediterranean and European regions show varying levels of treatment coverage. Countries like Georgia and Iceland have achieved remarkable treatment success rates, while others continue to face challenges in providing universal access to DAA therapies. The Western Pacific region, including countries like Japan and Australia, has also made significant strides in HCV elimination efforts. The World Health Organization has set ambitious targets for Hepatitis C elimination by 2030, aiming for 90% reduction in new infections and 65% reduction in mortality. Many countries have developed national elimination strategies, focusing on improving diagnosis rates, ensuring treatment access, and preventing new infections among high-risk populations. Our interactive visualization allows you to compare active cases with total treated populations, analyze treatment success rates by country, and understand regional progress toward HCV elimination. This data is invaluable for healthcare professionals, researchers, policymakers, and public health advocates working toward a world free of Hepatitis C. The statistics presented are based on WHO estimates for 2022 and represent both the number of people living with chronic Hepatitis C infection and those who have achieved sustained virologic response (cure) through treatment. Regular monitoring of these trends helps evaluate the effectiveness of national and global elimination strategies.Understanding Hepatitis C and Treatment Success
Hepatitis C Cases by Country
#
1
8,790,812
10,794,232
2022
2
2,663,597
2,807,219
2022
3
1,392,645
1,404,685
2022
4
1,349,056
1,357,901
2022
5
1,250,706
1,303,336
2022
6
1,065,843
1,157,817
2022
7
890,997
963,512
2022
8
691,928
700,145
2022
9
678,258
703,699
2022
10
535,868
693,314
2022
11
516,676
533,985
2022
12
511,036
531,211
2022
13
484,523
4,328,245
2022
14
476,477
497,450
2022
15
448,150
778,615
2022
16
442,797
444,445
2022
17
432,499
432,523
2022
18
427,470
430,092
2022
19
424,996
430,103
2022
20
398,610
398,610
2022
21
383,180
426,777
2022
22
374,514
394,350
2022
23
356,043
356,324
2022
24
309,159
314,618
2022
25
293,845
306,981
2022
26
289,279
293,151
2022
27
288,767
317,435
2022
28
273,188
288,704
2022
29
261,968
269,978
2022
30
257,189
285,945
2022
31
243,978
245,403
2022
32
242,440
242,892
2022
33
217,242
256,580
2022
34
211,999
214,696
2022
35
211,114
211,413
2022
36
205,380
236,870
2022
37
203,665
213,514
2022
38
198,612
201,315
2022
39
196,671
196,671
2022
40
183,160
206,158
2022
41
182,952
182,962
2022
42
170,824
177,663
2022
43
170,319
172,436
2022
44
165,254
167,660
2022
45
163,992
177,063
2022
46
159,493
162,399
2022
47
157,542
175,178
2022
48
153,690
158,659
2022
49
147,255
156,491
2022
50
142,921
142,921
2022
51
140,273
140,811
2022
52
136,999
136,999
2022
53
136,081
142,941
2022
54
133,727
140,426
2022
55
130,380
209,367
2022
56
129,880
131,530
2022
57
128,501
190,095
2022
58
125,566
135,145
2022
59
120,135
125,400
2022
60
120,082
120,355
2022
61
117,953
117,953
2022
62
111,828
114,296
2022
63
108,210
108,210
2022
64
103,759
105,087
2022
65
103,262
103,267
2022
66
101,947
101,947
2022
67
100,920
124,150
2022
68
99,576
99,604
2022
69
97,936
204,418
2022
70
96,623
99,313
2022
71
92,900
92,900
2022
72
88,916
155,188
2022
73
73,675
76,887
2022
74
72,090
75,881
2022
75
71,450
73,908
2022
76
66,794
66,794
2022
77
66,593
67,032
2022
78
66,199
67,050
2022
79
64,279
65,109
2022
80
62,610
62,610
2022
81
62,536
62,536
2022
82
62,271
65,807
2022
83
62,170
118,841
2022
84
57,756
58,253
2022
85
56,578
58,144
2022
86
54,692
68,734
2022
87
54,676
54,676
2022
88
53,466
54,080
2022
89
53,036
63,210
2022
90
48,600
126,073
2022
91
46,261
46,261
2022
92
44,056
48,541
2022
93
42,170
44,722
2022
94
41,888
43,641
2022
95
40,418
50,484
2022
96
40,000
40,000
2022
97
39,618
40,134
2022
98
37,632
38,682
2022
99
35,557
36,009
2022
100
31,353
32,286
2022
101
30,720
42,392
2022
102
30,583
30,845
2022
103
30,456
30,458
2022
104
30,000
30,000
2022
105
29,788
45,063
2022
106
27,836
28,637
2022
107
27,407
27,407
2022
108
26,787
29,239
2022
109
25,650
25,650
2022
110
24,372
25,633
2022
111
23,820
28,468
2022
112
22,410
22,410
2022
113
21,012
24,957
2022
114
20,829
21,007
2022
115
20,745
30,719
2022
116
20,000
20,000
2022
117
19,212
21,362
2022
118
18,451
31,320
2022
119
18,188
18,248
2022
120
17,984
17,984
2022
121
17,219
17,844
2022
122
17,020
17,703
2022
123
16,989
22,255
2022
124
16,178
16,178
2022
125
15,949
16,606
2022
126
15,727
15,930
2022
127
15,679
18,540
2022
128
15,473
18,370
2022
129
15,035
15,036
2022
130
14,771
14,798
2022
131
14,397
14,426
2022
132
12,759
12,759
2022
133
12,423
12,423
2022
134
10,690
10,762
2022
135
10,406
10,476
2022
136
9,975
9,975
2022
137
9,354
9,688
2022
138
9,312
9,375
2022
139
9,164
28,912
2022
140
8,551
8,552
2022
141
7,844
7,844
2022
142
7,665
9,017
2022
143
7,466
7,777
2022
144
7,388
7,773
2022
145
7,293
7,293
2022
146
7,136
7,452
2022
147
6,183
6,183
2022
148
5,539
5,825
2022
149
4,959
5,134
2022
150
4,838
4,872
2022
151
4,648
5,514
2022
152
4,377
4,437
2022
153
3,798
3,930
2022
154
3,048
3,048
2022
155
2,859
2,980
2022
156
2,515
2,604
2022
157
2,504
2,589
2022
158
2056
2056
2022
159
1847
1959
2022
160
1718
1781
2022
161
1695
1718
2022
162
1353
1353
2022
163
1318
2,380
2022
164
1243
1243
2022
165
1216
1216
2022
166
1098
1138
2022
167
1078
1078
2022
168
1050
1050
2022
169
982
982
2022
170
769
796
2022
171
700
700
2022
172
694
694
2022
173
632
655
2022
174
591
616
2022
175
575
595
2022
176
456
466
2022
177
415
415
2022
178
299
306
2022
179
279
1253
2022
180
241
384
2022
181
180
180
2022
182
170
170
2022
183
126
126
2022
184
113
113
2022
185
110
180
2022
186
102
166
2022
187
19
19
2022
Global Distribution and Treatment Progress
The Path to Elimination
Using This Data
Frequently Asked Questions
Q: What is the difference between active Hepatitis C cases and total including cured?
A: Active cases represent people currently living with chronic Hepatitis C infection who require treatment or monitoring. The "total including cured" number adds those who have been successfully treated and achieved sustained virologic response (SVR), meaning the virus is no longer detectable in their blood. The difference between these numbers shows treatment success. For example, Egypt has 484,523 active cases but 4,328,245 total including cured, meaning approximately 3.8 million people have been successfully treated. This demonstrates the effectiveness of modern direct-acting antiviral therapies and national elimination programs.
Q: Can Hepatitis C be completely cured, and how effective are current treatments?
A: Yes, Hepatitis C can be completely cured with modern antiviral medications. Direct-acting antivirals (DAAs), introduced in the 2010s, have cure rates exceeding 95% with treatment courses lasting just 8-12 weeks. These medications work by targeting specific proteins the virus needs to replicate. Once cured (achieving sustained virologic response), the virus is eliminated from the body, though patients should continue liver monitoring if they had advanced disease. Unlike Hepatitis B, there is no chronic carrier state after successful HCV treatment. The main challenges now are ensuring diagnosis and treatment access, particularly in low-resource settings, rather than treatment efficacy itself.
Data Disclaimer: Projected data (future years) are estimates based on mathematical models. Actual values may differ. Learn about our methodology →
Sources
-
Updated: 07.11.2025https://www.who.int/data/gho/data/indicators/indicator-details/GHO/hepatitis---number-of-persons-living-with-chronic-hepatitis
Please log in to leave a comment.
Log in
(0) Comments